20-F/A: SHL Telemedicine Amends 20-F Filing, Cites Control Weaknesses and Corrects Errors

SHL Telemedicine files an amendment to its 20-F report, addressing disclosure control weaknesses and correcting typographical errors.

Summary

• SHL Telemedicine Ltd. is filing an amendment to its Annual Report on Form 20-F for the fiscal year ended December 31, 2023.
• The amendment addresses weaknesses in disclosure controls and procedures, including internal control over financial reporting.
• Management concluded that disclosure controls and procedures were not effective as of December 31, 2023, due to material weaknesses in Information Technology General Controls (ITGC).
• The company is implementing remediation activities to address these weaknesses.
• The filing also corrects typographical errors and updates certifications from the CEO and CFO.
• The company's financial statements are prepared in accordance with IFRS.
• The company had approximately 583 full-time employees as of December 31, 2023.
• The company operates in three geographic segments: Israel, Europe, and the Rest of the World.
• The company's primary focus is the development of technologies, solutions, and advanced telemedicine services to assess and monitor acute and chronic heart health and cardiac diseases.
• The company's key product is the SmartHeart platform, a unique advanced technology that is the only full ECG 12 lead ECG that enables a hospital-quality full ECG to be performed by a lay-person without the assistance of a healthcare professional.

Sentiment

Score: 4

Explanation: The document highlights control weaknesses, which is a negative signal, but also indicates remediation efforts, leading to a neutral to slightly negative sentiment.

Positives

• The company is taking steps to remediate the identified material weaknesses in internal control over financial reporting.
• The company is committed to ensuring that its internal control over financial reporting is designed and operating effectively.
• The company is replacing important elements of its ITGCs as they relate to financial reporting and are incorporating them into the design of its processes and controls within a new enterprise resource planning system, which is expected to be effective during 2025.

Negatives

• The company identified material weaknesses in its IT general controls, leading to a conclusion that disclosure controls and procedures were not effective as of December 31, 2023.
• The company's management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) promulgated under the Exchange Act.

Risks

• The company's management concluded that its disclosure controls and procedures were not effective as of December 31, 2023, due to material weaknesses in Information Technology General Controls (ITGC).
• The company's management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) promulgated under the Exchange Act.

Future Outlook

The company is implementing remediation activities to address the identified material weaknesses and expects a new enterprise resource planning system to be effective during 2025.

Industry Context

The telemedicine industry is subject to evolving regulations and increasing competition, requiring companies to maintain strong internal controls and adapt to changing market conditions.

Management Changes

Stakeholder Impact

• Shareholders may experience short-term uncertainty due to the identified control weaknesses.
• Employees may be involved in remediation efforts and new system implementations.
• Customers and suppliers are unlikely to be directly impacted, but the company's long-term stability is important to these stakeholders.
• Creditors may monitor the company's progress in addressing the control weaknesses.

Next Steps

• Implement and monitor remediation activities to address material weaknesses in ITGC.
• Ensure the new enterprise resource planning system is effective during 2025.
• Continue to review and improve financial reporting processes.

Key Dates

Keywords

internal control, disclosure controls, financial reporting, telemedicine, SHL Telemedicine, material weakness, ITGC, amendment, 20-F, certifications